{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:05:19Z","timestamp":1789790719609,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009881","name":"Regione Liguria","doi-asserted-by":"publisher","award":["Liguria project 25L02 \u201cRegistro tumori\""],"award-info":[{"award-number":["Liguria project 25L02 \u201cRegistro tumori\""]}],"id":[{"id":"10.13039\/501100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CUP J19I24001430001"],"award-info":[{"award-number":["CUP J19I24001430001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004770","name":"Universit\u00e0 degli Studi di Parma","doi-asserted-by":"publisher","award":["Bando di Ateneo 2024 per la ricerca"],"award-info":[{"award-number":["Bando di Ateneo 2024 per la ricerca"]}],"id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11259-026-11428-5","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:42:14Z","timestamp":1785210134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cross-species oncolytic virotherapy in vitro: BoHV4EGFP\u0394TK as a novel candidate against canine osteosarcoma and histiocytic sarcoma"],"prefix":"10.1007","volume":"50","author":[{"given":"Di Pentima","family":"Melania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minesso","family":"Sergio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franceschi","family":"Valentina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di Lecce","family":"Rosanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corradi","family":"Attilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borghetti","family":"Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donofrio","family":"Gaetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razzuoli","family":"Elisabetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fruscione","family":"Floriana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baumg\u00e4rtner","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vescovini","family":"Rosanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrani","family":"Melania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basini","family":"Giuseppina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bussolati","family":"Simona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Passeri","family":"Benedetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"11428_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/CAAC.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108. https:\/\/doi.org\/10.3322\/CAAC.21262","journal-title":"CA Cancer J Clin"},{"key":"11428_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/J.1748-5827.2010.00974.X","volume":"51","author":"VJ Adams","year":"2010","unstructured":"Adams VJ, Evans KM, Sampson J, Wood JLN (2010) Methods and mortality results of a health survey of purebred dogs in the UK. J Small Anim Pract 51:512\u2013524. https:\/\/doi.org\/10.1111\/J.1748-5827.2010.00974.X","journal-title":"J Small Anim Pract"},{"key":"11428_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/S13028-017-0341-9","volume":"59","author":"S Simpson","year":"2017","unstructured":"Simpson S, Dunning MD, de Brot S, Grau-Roma L, Mongan NP, Rutland CS (2017) Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. Acta Vet Scand 59:71. https:\/\/doi.org\/10.1186\/S13028-017-0341-9","journal-title":"Acta Vet Scand"},{"key":"11428_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/J.CVSM.2019.04.009","volume":"49","author":"C Mullin","year":"2019","unstructured":"Mullin C, Clifford CA (2019) Histiocytic sarcoma and hemangiosarcoma update. Vet Clin North Am Small Anim Pract 49:855\u2013879. https:\/\/doi.org\/10.1016\/J.CVSM.2019.04.009","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"11428_CR5","doi-asserted-by":"publisher","unstructured":"Zapata I, Moraes LE, Fiala EM, Zaldivar-Lopez S, Couto CG, Rowell JL et al (2019) Risk-modeling of dog osteosarcoma genome scans shows individuals with Mendelian-level polygenic risk are common. BMC Genomics 20. https:\/\/doi.org\/10.1186\/S12864-019-5531-6","DOI":"10.1186\/S12864-019-5531-6"},{"key":"11428_CR6","doi-asserted-by":"crossref","unstructured":"Dernell WS, Ehrhart NP, Straw RC, Vail DM (2007) Tumor of the skeletal system. In: Withrow SJ, Vail DM (Eds.) Small Animal Clinical Oncology, 4th Edition, pp 540\u2013582. - References - Scientific Research Publishing. https:\/\/www.scirp.org\/reference\/referencespapers?referenceid=940598. Accessed 9 Dec 2025","DOI":"10.1016\/B978-072160558-6.50026-5"},{"key":"11428_CR7","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1158\/1078-0432.CCR-24-1854","volume":"30","author":"S Patkar","year":"2024","unstructured":"Patkar S, Mannheimer J, Harmon SA, Ramirez CJ, Mazcko CN, Choyke PL et al (2024) Large-scale comparative analysis of canine and human osteosarcomas uncovers conserved clinically relevant tumor microenvironment subtypes. Clin Cancer Res 30:5630\u20135642. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-1854","journal-title":"Clin Cancer Res"},{"key":"11428_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/0300985813510413","volume":"51","author":"PF Moore","year":"2014","unstructured":"Moore PF (2014) A review of histiocytic diseases of dogs and cats. Vet Pathol 51:167\u2013184. https:\/\/doi.org\/10.1177\/0300985813510413","journal-title":"Vet Pathol"},{"key":"11428_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1354\/VP.43-5-632","volume":"43","author":"PF Moore","year":"2006","unstructured":"Moore PF, Affolter VK, Vernau W (2006) Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages. Vet Pathol 43:632\u2013645. https:\/\/doi.org\/10.1354\/VP.43-5-632","journal-title":"Vet Pathol"},{"key":"11428_CR10","doi-asserted-by":"publisher","unstructured":"Berg DR, Offord CP, Kemler I, Ennis MK, Chang L, Paulik G et al (2019) In vitro and in silico multidimensional modeling of oncolytic tumor virotherapy dynamics. PLoS Comput Biol 15. https:\/\/doi.org\/10.1371\/JOURNAL.PCBI.1006773","DOI":"10.1371\/JOURNAL.PCBI.1006773"},{"key":"11428_CR11","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez D, Cesarman-Maus G, Amador-Molina A, Lizano M (2018) Oncolytic viruses for canine cancer treatment. Cancers (Basel) 10. https:\/\/doi.org\/10.3390\/CANCERS10110404","DOI":"10.3390\/CANCERS10110404"},{"key":"11428_CR12","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/V6062340","volume":"6","author":"S Lapp","year":"2014","unstructured":"Lapp S, Pfankuche VM, Baumg\u00e4rtner W, Puff C (2014) Viral oncolysis - can insights from measles be transferred to canine distemper virus? Viruses 6:2340\u20132375. https:\/\/doi.org\/10.3390\/V6062340","journal-title":"Viruses"},{"key":"11428_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/JNCI\/DJJ111","volume":"98","author":"K Garber","year":"2006","unstructured":"Garber K (2006) China approves world\u2019s first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst 98:298\u2013300. https:\/\/doi.org\/10.1093\/JNCI\/DJJ111","journal-title":"J Natl Cancer Inst"},{"key":"11428_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/NRD4643","volume":"14","author":"E Dolgin","year":"2015","unstructured":"Dolgin E (2015) Oncolytic viruses get a boost with first FDA-approval recommendation. Nat Rev Drug Discov 14:369\u2013371. https:\/\/doi.org\/10.1038\/NRD4643","journal-title":"Nat Rev Drug Discov"},{"key":"11428_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1525-0016(02)00049-7","volume":"7","author":"A Hemminki","year":"2003","unstructured":"Hemminki A, Kanerva A, Kremer EJ, Bauerschmitz GJ, Smith BF, Liu B et al (2003) A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model. Mol Ther 7:163\u2013173. https:\/\/doi.org\/10.1016\/S1525-0016(02)00049-7","journal-title":"Mol Ther"},{"key":"11428_CR16","doi-asserted-by":"publisher","unstructured":"Armando F, Fayyad A, Arms S, Barthel Y, Schaudien D, Rohn K et al (2021) Intratumoral canine distemper virus infection inhibits tumor growth by modulation of the tumor microenvironment in a murine xenograft model of canine histiocytic sarcoma. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/IJMS22073578","DOI":"10.3390\/IJMS22073578"},{"key":"11428_CR17","doi-asserted-by":"publisher","unstructured":"Armando F, Gambini M, Corradi A, Giudice C, Pfankuche VM, Brogden G et al (2020) Oxidative stress in canine histiocytic sarcoma cells induced by an infection with canine distemper virus led to a dysregulation of HIF-1\u03b1 Downstream pathway resulting in a reduced expression of VEGF-B in vitro. Viruses 12. https:\/\/doi.org\/10.3390\/V12020200","DOI":"10.3390\/V12020200"},{"key":"11428_CR18","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.1111\/JCMM.15585","volume":"24","author":"F Armando","year":"2020","unstructured":"Armando F, Gambini M, Corradi A, Becker K, Marek K, Pfankuche VM et al (2020) Mesenchymal to epithelial transition driven by canine distemper virus infection of canine histiocytic sarcoma cells contributes to a reduced cell motility in vitro. J Cell Mol Med 24:9332\u20139348. https:\/\/doi.org\/10.1111\/JCMM.15585","journal-title":"J Cell Mol Med"},{"key":"11428_CR19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/JCMM.13023","volume":"21","author":"VM Pfankuche","year":"2017","unstructured":"Pfankuche VM, Spitzbarth I, Lapp S, Ulrich R, Deschl U, Kalkuhl A et al (2017) Reduced angiogenic gene expression in morbillivirus-triggered oncolysis in a translational model for histiocytic sarcoma. J Cell Mol Med 21:816\u2013830. https:\/\/doi.org\/10.1111\/JCMM.13023","journal-title":"J Cell Mol Med"},{"key":"11428_CR20","doi-asserted-by":"publisher","unstructured":"Qiu W, Ding X, Li S, He Y, Zhu L (2021) Oncolytic bovine herpesvirus 1 inhibits human lung adenocarcinoma A549 cell proliferation and tumor growth by inducing DNA damage. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/IJMS22168582","DOI":"10.3390\/IJMS22168582"},{"key":"11428_CR21","doi-asserted-by":"publisher","unstructured":"Davola ME, Cormier O, Vito A, El-Sayes N, Collins S, Salem O et al (2023) Oncolytic BHV-1 Is sufficient to induce immunogenic cell death and synergizes with low-dose chemotherapy to dampen immunosuppressive t regulatory cells. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/CANCERS15041295","DOI":"10.3390\/CANCERS15041295"},{"key":"11428_CR22","doi-asserted-by":"publisher","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-05-1076","volume":"65","author":"L Gillet","year":"2005","unstructured":"Gillet L, Dewals B, Farnir F, De Leval L, Vanderplasschen A (2005) Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. Cancer Res 65:9463\u20139472. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1076","journal-title":"Cancer Res"},{"key":"11428_CR23","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1128\/JVI.78.5.2336-2347.2004","volume":"78","author":"L Gillet","year":"2004","unstructured":"Gillet L, Minner F, Detry B, Farnir F, Willems L, Lambot M et al (2004) Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis. J Virol 78:2336\u20132347. https:\/\/doi.org\/10.1128\/JVI.78.5.2336-2347.2004","journal-title":"J Virol"},{"key":"11428_CR24","doi-asserted-by":"publisher","unstructured":"Hong B, Sahu U, Mullarkey MP, Kaur B (2022) Replication and spread of oncolytic herpes simplex virus in solid tumors. Viruses 14. https:\/\/doi.org\/10.3390\/V14010118","DOI":"10.3390\/V14010118"},{"key":"11428_CR25","doi-asserted-by":"publisher","unstructured":"Redaelli M, Mucignat-Caretta C, Cavaggioni A, Caretta A, D\u2019Avella D, Denaro L et al (2010) Bovine herpesvirus 4 based vector as a potential oncolytic-virus for treatment of glioma. Virol J 7. https:\/\/doi.org\/10.1186\/1743-422X-7-298","DOI":"10.1186\/1743-422X-7-298"},{"key":"11428_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1099\/VIR.0.80718-0","volume":"86","author":"L Gillet","year":"2005","unstructured":"Gillet L, Daix V, Donofrio G, Wagner M, Koszinowski UH, China B et al (2005) Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. J Gen Virol 86:907\u2013917. https:\/\/doi.org\/10.1099\/VIR.0.80718-0","journal-title":"J Gen Virol"},{"key":"11428_CR27","doi-asserted-by":"publisher","unstructured":"Chirullo B, Fruscione F, Del Zotto G, Dell\u2019Anno F, Tarantino M, Porcellato I et al (2024) Evaluation of attenuated Salmonella Typhimurium (STM\u2206znuABC) anticancer activity on canine mammary cancer-associated fibroblasts. Res Vet Sci 180. https:\/\/doi.org\/10.1016\/J.RVSC.2024.105438","DOI":"10.1016\/J.RVSC.2024.105438"},{"key":"11428_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0166-0934(01)00419-0","volume":"101","author":"G Donofrio","year":"2002","unstructured":"Donofrio G, Cavirani S, Simone T, Van Santen VL (2002) Potential of bovine herpesvirus 4 as a gene delivery vector. J Virol Methods 101:49\u201361. https:\/\/doi.org\/10.1016\/S0166-0934(01)00419-0","journal-title":"J Virol Methods"},{"key":"11428_CR29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1128\/CVI.00200-06","volume":"13","author":"G Donofrio","year":"2006","unstructured":"Donofrio G, Cavirani S, Vanderplasschen A, Gillet L, Flammini CF (2006) Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model. Clin Vaccine Immunol 13:1246\u20131254. https:\/\/doi.org\/10.1128\/CVI.00200-06","journal-title":"Clin Vaccine Immunol"},{"key":"11428_CR30","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2460\/JAVMA.21.11.0498","volume":"260","author":"RM Doka","year":"2022","unstructured":"Doka RM, Suter SE, Mastromauro ML, Bennett AL, Hess PR (2022) Doxorubicin for treatment of histiocytic sarcoma in dogs: 31 cases (2003\u20132017). J Am Vet Med Assoc 260:1827\u20131833. https:\/\/doi.org\/10.2460\/JAVMA.21.11.0498","journal-title":"J Am Vet Med Assoc"},{"key":"11428_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/S11259-014-9623-0","volume":"39","author":"M Szewczyk","year":"2015","unstructured":"Szewczyk M, Lechowski R, Zabielska K (2015) What do we know about canine osteosarcoma treatment? Review. Vet Res Commun 39:61\u201367. https:\/\/doi.org\/10.1007\/S11259-014-9623-0","journal-title":"Vet Res Commun"},{"key":"11428_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/NCPONC0736","volume":"4","author":"TC Liu","year":"2007","unstructured":"Liu TC, Galanis E, Kirn D (2007) Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat Clin Pract Oncol 4:101\u2013117. https:\/\/doi.org\/10.1038\/NCPONC0736","journal-title":"Nat Clin Pract Oncol"},{"key":"11428_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/S11262-020-01802-Z","volume":"57","author":"T Aligholipour Farzani","year":"2021","unstructured":"Aligholipour Farzani T, Bilge Dagalp S, Ozkul A, Gurdal H, Dogan F, Alkan F (2021) Assessment of replication of bovine herpesvirus type 4 in human glioblastoma and breast cancer cells as a potential oncolytic virus. Virus Genes 57:31\u201339. https:\/\/doi.org\/10.1007\/S11262-020-01802-Z","journal-title":"Virus Genes"},{"key":"11428_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/CGT.2009.77","volume":"17","author":"R Rodrigues","year":"2010","unstructured":"Rodrigues R, Cuddington B, Mossman K (2010) Bovine herpesvirus type 1 as a novel oncolytic virus. Cancer Gene Ther 17:344\u2013355. https:\/\/doi.org\/10.1038\/CGT.2009.77","journal-title":"Cancer Gene Ther"},{"key":"11428_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1530\/REP-07-0065","volume":"134","author":"G Donofrio","year":"2007","unstructured":"Donofrio G, Herath S, Sartori C, Cavirani S, Flammini CF, Sheldon IM (2007) Bovine herpesvirus 4 is tropic for bovine endometrial cells and modulates endocrine function. Reproduction 134:183\u2013197. https:\/\/doi.org\/10.1530\/REP-07-0065","journal-title":"Reproduction"},{"key":"11428_CR36","doi-asserted-by":"publisher","unstructured":"Righi C, Franzoni G, Feliziani F, Jones C, Petrini S (2023) The cell-mediated immune response against bovine alphaherpesvirus 1 (BoHV-1) infection and vaccination. Vaccines (Basel) 11. https:\/\/doi.org\/10.3390\/VACCINES11040785","DOI":"10.3390\/VACCINES11040785"},{"key":"11428_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1051\/VETRES:2006059","volume":"38","author":"B Muylkens","year":"2007","unstructured":"Muylkens B, Thiry J, Kirten P, Schynts F, Thiry E (2007) Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis. Vet Res 38:181\u2013209. https:\/\/doi.org\/10.1051\/VETRES:2006059","journal-title":"Vet Res"},{"key":"11428_CR38","doi-asserted-by":"publisher","unstructured":"Alves Dummer L, Pereira Leivas Leite F, Van Littel-Van Den Hurk D (2014) Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinology. Vet Res 45. https:\/\/doi.org\/10.1186\/S13567-014-0111-X","DOI":"10.1186\/S13567-014-0111-X"},{"key":"11428_CR39","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/J.TCB.2025.02.011","volume":"35","author":"T Zhao","year":"2025","unstructured":"Zhao T, Chi Z, Wang D (2025) Versatility of gasdermin D beyond pyroptosis. Trends Cell Biol 35:1039\u20131053. https:\/\/doi.org\/10.1016\/J.TCB.2025.02.011","journal-title":"Trends Cell Biol"},{"key":"11428_CR40","doi-asserted-by":"publisher","unstructured":"Pfankuche VM, Sayed-Ahmed M, Contioso VB, Spitzbarth I, Rohn K, Ulrich R et al (2016) Persistent morbillivirus infection leads to altered cortactin distribution in histiocytic sarcoma cells with decreased cellular migration capacity. PLoS ONE 11. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0167517","DOI":"10.1371\/JOURNAL.PONE.0167517"},{"key":"11428_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/JVIM.16946","volume":"38","author":"Y Kim","year":"2023","unstructured":"Kim Y, Park J, Kim B, Yu KR, Kim HS, Oh Y et al (2023) Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. J Vet Intern Med 38:300. https:\/\/doi.org\/10.1111\/JVIM.16946","journal-title":"J Vet Intern Med"},{"key":"11428_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/VCO.12848","volume":"20","author":"P Colombe","year":"2022","unstructured":"Colombe P, B\u00e9guin J, Benchekroun G, Le Roux D (2022) Blood biomarkers for canine cancer, from human to veterinary oncology. Vet Comp Oncol 20:767. https:\/\/doi.org\/10.1111\/VCO.12848","journal-title":"Vet Comp Oncol"},{"key":"11428_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/J.1476-5829.2010.00238.X","volume":"9","author":"H Von Euler","year":"2011","unstructured":"Von Euler H, Eriksson S (2011) Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases. Vet Comp Oncol 9:1\u201315. https:\/\/doi.org\/10.1111\/J.1476-5829.2010.00238.X","journal-title":"Vet Comp Oncol"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-026-11428-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-026-11428-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-026-11428-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:55:20Z","timestamp":1789790120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-026-11428-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11428"],"URL":"https:\/\/doi.org\/10.1007\/s11259-026-11428-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9772372\/v1","asserted-by":"object"}]},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There was no need for animal ethic committee for this in vitro study.","order":1,"name":"Ethics","label":"Ethic approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"487"}}